Global OTC/DTC Infectious Disease Diagnostics Market Report 2022: Industry Structure - The Theranos Legacy & The Diagnostic Plight of Pharmacies
January 17, 2022 04:58 ET
|
Research and Markets
Dublin, Jan. 17, 2022 (GLOBE NEWSWIRE) -- ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.com CONTACT: CONTACT: ResearchAndMarkets.com
Laura Wood, Senior...
Virology Specimen Collection Industry Trends & Opportunities 2021-2026 Featuring Analysis of BD, Quidel, Thermo Fisher Scientific, Trinity Biotech, Titan Biotech, Diasorin, Vircell, and More
January 17, 2022 04:48 ET
|
Research and Markets
Dublin, Jan. 17, 2022 (GLOBE NEWSWIRE) -- The "Global Virology Specimen Collection Market by Product (Viral Transport Media, Swabs, Blood Collection Kits, Specimen Collection Tubes), Sample Type...
Global Dengue Testing Markets, 2026 - ELISA-based Tests Expected to Dominate, Asia-Pacific the Fastest Growing Market
December 22, 2021 08:13 ET
|
Research and Markets
Dublin, Dec. 22, 2021 (GLOBE NEWSWIRE) -- The "Dengue Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021-2026)" report has been added to ResearchAndMarkets.com's offering. The...
The new Omicron variant: What we know and don’t know
December 01, 2021 05:56 ET
|
University of the Free state
Bloemfontein, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Even though not much is yet known about the new COVID-19 variant, Omicron, the presence of a high number of mutations – more than 30 – in the spike...
The Worldwide Healthcare Analytical Testing Services Industry is Expected to Reach $9.8 Billion by 2026
November 17, 2021 10:08 ET
|
Research and Markets
Dublin, Nov. 17, 2021 (GLOBE NEWSWIRE) -- The "Global Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-based Assays, Stability Testing, Heavy Metal...
AXIM Biotechnologies’ Development of Rapid Test for COVID-19 Neutralizing Antibodies is Cited to Demonstrate over 90% Sensitivity and 100% Specificity
November 09, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19...
Global Molecular Diagnostics Market for Infectious Disease Executive Guide 2021: Multiplex Testing May Take Center Stage
November 05, 2021 05:08 ET
|
Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With COVID-19 Impact & Forecasting/Analysis, and Executive...
ONCOTELIC ANNOUNCES UPDATE ON THE OT-101 CLINICAL PROGRAMS INCLUDING C001 COVID STUDY
October 20, 2021 07:00 ET
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), a leading developer of TGF-β therapeutics for oncology and virology...
Global OTC/DTC Infectious Disease Diagnostics Markets, 2021-2025 - Privacy and Anonymity / The Internet Effect / Rapid Results / The Wellness Movement / The COVID-19 Impact
October 12, 2021 06:33 ET
|
Research and Markets
Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, Opportunity Analysis 2021 to 2025" report has been added to ResearchAndMarkets.com's...
Provectus Biopharmaceuticals Provides Update on Research into Oral Administration of PV-10® Immunotherapy for Treatments of Hematology, Oncology, and Virology
October 04, 2021 09:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided an update on the Company’s research into the systemic administration of Provectus’ investigational...